Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
42.82
+0.02 (0.05%)
At close: May 29, 2026, 4:00 PM EDT
42.75
-0.07 (-0.16%)
After-hours: May 29, 2026, 7:13 PM EDT
Sionna Therapeutics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Sionna Therapeutics stock has a consensus rating of "Buy" and an average price target of $51.6. The average 1-year stock price forecast is 20.50% higher than the current stock price, while the lowest is $23 (-46.29%) and the highest is $63 (+47.13%).
Price Target: $51.6 (+20.50%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sionna Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 8 | 8 | 8 | 8 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $55 | Buy | Maintains | $55 | +28.44% | May 25, 2026 |
| Freedom Capital Markets | Freedom Capital Markets | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 20, 2026 |
| Wedbush | Wedbush | Buy Maintains $53 | Buy | Maintains | $53 | +23.77% | May 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $60 | Buy | Maintains | $60 | +40.12% | May 16, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $50 | Buy | Maintains | $50 | +16.77% | May 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.06M
EPS This Year
-2.52
from -1.88
EPS Next Year
-2.71
from -2.52
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 31.5M | ||||||
| Avg | n/a | 3.1M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.03 | -1.94 | ||||||
| Avg | -2.52 | -2.71 | ||||||
| Low | -3.16 | -3.80 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.